[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
December 26, 2001

Cervical Cancer Screening in Developing Countries—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(24):3079-3081. doi:10.1001/jama.286.24.3075

In Reply: Cytological screening has been available for more than 40 years, but less than 5% of women in the developing world have ever been screened.1 If the benefits of screening are to be extended to such women, safe and cost-effective alternatives to the Pap test must be identified. We disagree that our article may delay establishment of cytological screening. We evaluated alternative screening approaches because the infrastructure requirements and costs of cytological screening have essentially precluded its implementation in most of the developing world.

First Page Preview View Large
First page PDF preview
First page PDF preview
×